EpiPens can often make the difference when seconds count, and if they don't work it can be deadly.

Pfizer Canada is voluntarily recalling two lots of EpiPens in Canada, after two of the pens failed to work in other countries.

While none of the pens in Canada have failed, the company is recalling one lot of EpiPens auto-injector and one lot of EpiPens Jr. auto-injector.

The recalled devices may contain a defective part that could result in the auto-injector failing to activate or requiring increased force to activate.

Check for these lot numbers and expiry dates:


EpiPen (0.3 mg epinephrine) auto-injector lot 5GU763, expiry date May 2017, 67844 units distributed in Canada

EpiPen Jr (0.15 mg epinephrine) auto-injector lot 5GR765, expiry date March 2017, 39503 units distributed in Canada.

If you have one of the recalled pens return it to the pharmacy you got it at.

Pfizer Canada says to keep the affected EpiPen/EpiPen Jr. auto-injectors until a replacement is obtained.
   
If needed, before you get a replacement, use the recalled EpiPen then seek emergency medical attention.
    
Speak with your healthcare professional if you are concerned about your health.
    
Contact Pfizer Canada at 1-866-9 Pfizer (1-866-973-4937) or CorporateAffairsCanada@pfizer.com for more information on the recall.
    
Report adverse events to health products to Health Canada by calling toll-free at 1-866-234-2345, or by reporting online, by mail or by fax.
    
Report complaints about health products to Health Canada by calling toll-free at 1-800-267-9675, or complete an online complaint form.